Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 022156
Company: CHIESI
Company: CHIESI
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
CLEVIPREX | CLEVIDIPINE | 25MG/50ML (0.5MG/ML) | EMULSION;INTRAVENOUS | Prescription | None | Yes | Yes |
CLEVIPREX | CLEVIDIPINE | 50MG/100ML (0.5MG/ML) | EMULSION;INTRAVENOUS | Prescription | None | Yes | Yes |
CLEVIPREX | CLEVIDIPINE | 125MG/250ML (0.5MG/ML) | EMULSION;INTRAVENOUS | Discontinued | None | Yes | No |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
04/16/2021 | SUPPL-7 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022156s007lbl.pdf | |
12/08/2011 | SUPPL-3 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022156s003lbl.pdf |